ReviewBriefings in bioinformatics2026
An overview of self-supervised deep learning applications to molecular data.
Review in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The emergence of high-throughput sequencing technologies has generated unprecedented amounts of molecular data, posing significant challenges for analysis and interpretation. In the past 15 years, deep learning (DL) has revolutionized many data analysis fields. However, a key limitation of most DL approaches is their reliance on massive amounts of data that often require labeling. Self-supervised learning (SSL) uses large-scale unlabeled data to learn meaningful representations for specific tasks, allowing training of the models without labels. While SSL has primarily been applied to fields like natural language processing and medical image analysis, SSL can also be applied to molecular data to learn meaningful representations of molecular sequences that can be used for downstream tasks. Despite the growing interest in SSL applications using molecular data over the recent years, no comprehensive review has been published on this topic, so far, making it timely to address. This paper aims to provide researchers in DL and bioinformatics with a clear view of SSL omics applications to foster future work in the domain. This review examines the principles of SSL, such as foundation models, and it discusses the application of SSL to various omics data types, summarizes information from 17 studies, and categorizes applications by data type, detailing common tasks, model architectures, and repositories. Key applications such as DNABERT and Nucleotide Transformer are highlighted, demonstrating the contributions of SSL in understanding gene regulation. Future directions for SSL in omics are outlined, emphasizing the potential for integrating multi-omics data and developing more sophisticated pretext tasks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.